🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AEG35156 is a second generation antisense which targets XIAP mRNA to lower ...
Status
Completed
Location
Tuen Mun Hospital
Start Date
2009-03
Trial ID
NCT00882869
Treatments Being Tested
This is an open-label multicenter, phase 1-2 study. Following determination...
Status
Terminated
Location
Rocky Mountain Cancer Center
Start Date
2007-09
Trial ID
NCT00558922
Treatments Being Tested
This study is designed to find the maximum tolerated dose, safety and toxic...
Status
Terminated
Location
Christie Hospital NHS Trust
Start Date
2006-06
Trial ID
NCT00385775
Treatments Being Tested
AEG35156 has shown early evidence of activity in patients with advanced ind...
Status
Terminated
Location
Providence Saint-Joseph Medical Center
Start Date
2008-09
Trial ID
NCT00768339
Treatments Being Tested
This is an open-label multicenter, phase 1-2 study. Following determination...
Status
Terminated
Location
Scottsdale Healthcare - SHEA
Start Date
2007-09
Trial ID
NCT00557596
Treatments Being Tested
This is an open-label multicenter, phase 1-2 study. Following determination...
Status
Terminated
Location
Rocky Mountain Cancer Center
Start Date
2007-11
Trial ID
NCT00558545
Treatments Being Tested